Fusion Pharmaceuticals Inc (DELISTED) (FUSN:DL)
21.55
0.00 (0.00%)
USD |
NASDAQ |
Jun 04, 16:00
Fusion Pharmaceuticals Total Liabilities (Quarterly): 81.98M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 81.98M |
December 31, 2023 | 63.36M |
September 30, 2023 | 64.91M |
June 30, 2023 | 65.32M |
March 31, 2023 | 65.72M |
December 31, 2022 | 56.84M |
September 30, 2022 | 55.35M |
June 30, 2022 | 29.23M |
March 31, 2022 | 20.53M |
Date | Value |
---|---|
December 31, 2021 | 20.82M |
September 30, 2021 | 21.81M |
June 30, 2021 | 18.60M |
March 31, 2021 | 18.24M |
December 31, 2020 | 16.16M |
September 30, 2020 | 5.605M |
June 30, 2020 | 7.903M |
March 31, 2020 | 15.05M |
December 31, 2019 | 102.89M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.605M
Minimum
Sep 2020
102.89M
Maximum
Dec 2019
40.57M
Average
25.52M
Median
Total Liabilities (Quarterly) Benchmarks
AstraZeneca PLC | 64.79B |
Landos Biopharma Inc (DELISTED) | 6.742M |
Acasti Pharma Inc | 11.56M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 323.81M |
Shareholders Equity (Quarterly) | 241.83M |